Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
01/17/2025 | CALL | $2.50 | 106 | +5 | +4.95% |
12/20/2024 | CALL | $2.50 | 272 | 0 | |
12/20/2024 | CALL | $5.00 | 63 | 0 | |
12/20/2024 | CALL | $7.50 | 22 | 0 | |
12/20/2024 | PUT | $2.50 | 48 | 0 | |
12/20/2024 | PUT | $5.00 | 0 | 0 | |
06/20/2025 | CALL | $5.00 | 0 | 0 | |
06/20/2025 | CALL | $7.50 | 1 | 0 | |
06/20/2025 | PUT | $2.50 | 20 | 0 | |
06/20/2025 | PUT | $5.00 | 0 | 0 | |
06/20/2025 | PUT | $7.50 | 0 | 0 | |
03/21/2025 | CALL | $2.50 | 1,161 | -2 | -0.17% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Fidelity Growth Company Fund | 4.35% | 4.76M | 5.99M |
Fidelity Series Growth Company Fund | 1.52% | 1.66M | 2.1M |
Vanguard Total Stock Market Index Fund | 1.48% | 1.62M | 2.04M |
iShares Russell 2000 ETF | 1.02% | 1.11M | 1.4M |
Fidelity Growth Company K6 Fund | 0.82% | 892.97k | 1.13M |
Vanguard Extended Market Index Fund | 0.68% | 747.48k | 941.82k |
iShares Russell 2000 Value ETF | 0.47% | 512.72k | 646.02k |
Fidelity Small Cap Index Fund | 0.40% | 440.43k | 554.94k |
iShares NASDAQ Biotechnology ETF | 0.27% | 289.73k | 365.06k |
Price (T.Rowe) Health Sciences Fund | 0.26% | 288.95k | 364.08k |
Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference
11/06 09:01 am
GlobeNewswire Inc.
Read moreInvivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024
11/06 08:01 am
GlobeNewswire Inc.
Read moreInvivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024
10/16 07:01 am
GlobeNewswire Inc.
Read moreInvivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes
07/01 07:01 am
GlobeNewswire Inc.
Read moreInvivyd to Participate at the Jefferies Global Healthcare Conference
06/03 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
05/31 07:00 am
GlobeNewswire Inc.
Read moreInvivyd Elects Two New Independent Members to its Board of Directors
05/22 07:00 am
GlobeNewswire Inc.
Read moreInvivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
05/13 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
05/09 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
05/07 07:30 am
GlobeNewswire Inc.
Read moreInvivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
05/02 05:13 pm
GlobeNewswire Inc.
Read moreInvivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position
04/30 07:30 am
GlobeNewswire Inc.
Read moreInvivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
04/15 07:30 am
GlobeNewswire Inc.
Read moreInvivyd Announces CEO Transition
04/12 07:30 am
GlobeNewswire Inc.
Read moreKura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
04/05 08:01 am
Benzinga
Read moreInvivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
04/04 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
03/28 07:00 am
GlobeNewswire Inc.
Read moreTesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
03/26 10:36 am
Benzinga
Read moreAehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
03/25 10:32 am
Benzinga
Read moreInvivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial
03/22 03:28 pm
GlobeNewswire Inc.
Read moreInvivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
02/05 05:02 pm
GlobeNewswire Inc.
Read moreApple To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
01/18 08:50 am
Benzinga
Read moreAll You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy
01/12 01:00 pm
Zacks Investment Research
Read moreInvivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
12/23 06:29 am
The Motley Fool
Read moreInvivyd (IVVD) Surges on Positive Data From COVID-19 Study
12/19 12:52 pm
Zacks Investment Research
Read moreBluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
12/19 11:19 am
Benzinga
Read moreCrude Oil Rises 3%; US Housing Market Index Increases In December
12/18 01:17 pm
Benzinga
Read moreInvivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19
12/18 08:00 am
GlobeNewswire Inc.
Read moreInvivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights
11/02 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd to Participate in Upcoming Investor Conferences
10/31 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19
09/11 07:00 am
GlobeNewswire Inc.
Read moreInvivyd (IVVD) Stock Rises 18% in 3 Months: Here's Why
08/29 01:13 pm
Zacks Investment Research
Read moreInvivyd Reports Second Quarter 2023 Financial Results and Business Highlights
08/10 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results and Business Highlights
08/03 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd Announces Appointment of Sara Cotter to Board Of Directors
07/27 04:01 pm
GlobeNewswire Inc.
Read moreInvivyd Announces General Alignment with FDA on Pathway to Potential EUA for VYD222 and Anticipated Follow-On Monoclonal Antibody Candidates Designed to Prevent COVID-19
06/26 07:00 am
GlobeNewswire Inc.
Read moreInvivyd Announces Positive Initial Data from Ongoing Phase 1 Clinical Trial of VYD222, a Monoclonal Antibody Candidate in Development for the Prevention of Symptomatic COVID-19 in Immunocompromised People
06/22 07:00 am
GlobeNewswire Inc.
Read moreInvivyd to Participate at the Jefferies Healthcare Conference
06/01 07:00 am
GlobeNewswire Inc.
Read more